Heron Therapeutics Inc (NASDAQ: HRTX) is -38.30% lower on its value in year-to-date trading and has touched a low of $1.04 and a high of $3.73 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HRTX stock was last observed hovering at around $2.00 in the last trading session, with the day’s loss setting it -0.55%.
Currently trading at $1.45M, the stock is 6.14% and 3.69% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.12 million and changing 2117908% at the moment leaves the stock 13.36% off its SMA200. HRTX registered 37.91% gain for a year compared to 6-month gain of 27.88%.
The stock witnessed a 12.23% loss in the last 1 month and extending the period to 3 months gives it a -11.34%, and is 9.33% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.98% over the week and 3.16% over the month.
Heron Therapeutics Inc (HRTX) has around 122 employees, a market worth around $321.91M and $148.52M in sales. Fwd P/E is 31.65. Profit margin for the company is -5.24%. Distance from 52-week low is 102.88% and -43.43% from its 52-week high. The company has generated returns on investments over the last 12 months (-5.31%).
The EPS is expected to grow by 80.56% this year.
Heron Therapeutics Inc (HRTX) Top Institutional Holders
The shares outstanding are 152.43M, and float is at 151.11M with Short Float at 22.47%.
The top institutional shareholder in the company is RUBRIC CAPITAL MANAGEMENT LP with over 26.71 million shares valued at $93.5 million. The investor’s holdings represent 17.5395% of the HRTX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 8.62 million shares valued at $30.16 million to account for 5.657 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 8.33 million shares representing 5.4663% and valued at over $29.14 million, while ADAGE CAPITAL PARTNERS GP, L.L.C. holds 4.99 of the shares totaling 7.6 million with a market value of $26.6 million.
